VINPAI specializes in the manufacture and marketing of algae and plant-based functional ingredients for the food, cosmetics and medical industries. The activity is organized around 4 families of products: - functional ingredient solutions for the food industry: plant-based flavors, cheese solutions, dairy alternatives, salt reduction solutions, algal solutions for texturing, plant-based cookies, etc.; - algo-mineral solutions for the cosmetics industry: for the skin care and sun protection markets; - food supplements and nutraceutic actives: made from essential oils and marine bio-resources of algal origin; - algo-sourced solutions for medical devices: Cutaneous patches enriched in brown algae extracts and essential oils, molding powders designed to produce soft molds or imprints, aesthetic and dental hygiene products, etc.

Employees

Sector

Personal Products

More about the company

Quotes

Date	Price	Change	Volume
26-07-17	€3.200	+1.27%	30
26-07-16	€3.160	0.00%	0
26-07-15	€3.160	-9.71%	200
26-07-14	€3.500	0.00%	0
26-07-13	€3.500	0.00%	19

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-17 EDT			5-day change	1st Jan Change
3.200 ^EUR	+1.27%		-8.57%	-10.61%

07-16	Vinpai Reports Unaudited Revenue Results for the Second Quarter and First Half of Fiscal Year Ended June 30, 2026	CI
07-09	Camlin Fine Sciences Ownership in Vinpai Tops 95% After Cash Tender Offer	MT

Market Cap	14.51M 16.6M 13.39M 12.34M 23.26M 1.6B 23.78M 160M 62.95M 783M 62.36M 60.99M 2.7B	P/E 2024	-3.5x	P/E 2025	-3.34x
Enterprise Value	18.7M 21.4M 17.26M 15.91M 29.98M 2.06B 30.65M 206M 81.13M 1.01B 80.37M 78.61M 3.47B	EV / Sales 2024	1.79x	EV / Sales 2025	1.57x
Free-Float	5.61%	Yield 2024 *	-	Yield 2025	-

07-16	Vinpai Reports Unaudited Revenue Results for the Second Quarter and First Half of Fiscal Year Ended June 30, 2026	CI
07-09	Camlin Fine Sciences Ownership in Vinpai Tops 95% After Cash Tender Offer	MT
07-05	Camlin Fine Sciences Limited completed the acquisition o 11.00049 % stake in Vinpai SAS for ?1.8 million.	CI
06-19	The simplified tender offer for Vinpai shares opens Tuesday
06-19	French Financial Regulator Clears India's Camlin Fine Sciences' Offer for Remaining Vinpai Shares	MT
05-03	Camlin Fine Sciences Limited proposed to acquire remaining 15.60% stake in Vinpai SAS for ?2.6 million.	CI
05-03	Vinpai SAS Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-15	Hermès, Stellantis, Vinpai...stocks to watch today in Paris -
04-15	Vinpai: Losses widen in 2025 despite revenue growth
04-13	Weekly Earnings Calendar: JPMorgan and Netflix in the US, LVMH and ASML in Europe,
01-29	Vinpai Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
12-24	Sanofi, Synergie, Savencia... Stocks to Watch Today in Paris
12-24	CFSL Announces Postponement of Its Simplified Public Tender Offer for Vinpai

06-19	The simplified tender offer for Vinpai shares opens Tuesday
25-01-27	Invest Securities Downgrades Vinpai to Neutral, Cuts PT	MT
24-11-05	Vinpai: Invest Securities lowers its target price
24-10-03	Vinpai: Invest Securities reduces its target price on the stock
23-09-26	Vinpai: on the rise, an analyst initiates a buy on the stock

VINPAI Stock

Stocks

ALVIN

FR001400AXT1

Personal Products

Valuation: VINPAI

Chart: VINPAI

Latest news : VINPAI

Analysts' recommendations: VINPAI

Press Releases: VINPAI

News in other languages: VINPAI

Quotes and Performance

Course Extremes

Managers and Directors: VINPAI

Cosmetics & Perfumes

Financials

Company Profile

Quotes

Income Statement and Estimates

07-16	Vinpai Reports Revenue of €3.8 Million for the First Half of Its 2026 Fiscal Year	BU
07-08	Succes of the Simplified Tender Offer by CAMLIN FINE SCIENCES on Vinpai Shares	BU
06-18	French Stock Market Authority Clearance Decision Regarding the Mandatory Tender Offer by CAMLIN FINE SCIENCES on Vinpai Shares	BU
05-04	Filing on May 4, 2026 of the Draft of the Mandatory Tender Offer by CAMLIN FINE SCIENCES on Vinpai Shares	BU
04-15	VINPAI : Inside Information / News release on accounts, results	PU

07-16	Vinpai annonce un chiffre d’affaires de 3,8M€ au 1er semestre de son exercice 2026
07-08	Succès de l’offre publique d’achat simplifiée par CAMLIN FINE SCIENCES visant les actions de Vinpai
07-07	Camlin Fine Sciences dépasse les 90% du capital de Vinpai
06-19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
06-19	L'OPAS sur les actions Vinpai commence mardi

1 day	+1.27%
1 week	-8.57%
Current month	-11.11%
1 month	-10.11%
3 months	-9.60%
6 months	-10.11%
Current year	-10.61%

1 week	3.16	3.6
1 month	3.16	3.62
Current year	3.16	3.62
1 year	3.16	3.62
3 years	2.3	7.7
5 years	2.3	7.7
10 years	2.3	7.7

Director	Title	Age	Since
Alexandre de Selliers de Moranville BRD	Director/Board Member	79	2023-06-11
Cyrille Damany CHM	Chairman	66	2011-08-31
Philippe Le Ray BRD	Director/Board Member	58	2011-08-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VINPAI	+1.27%	-8.57%	-8.05%	-51.15%	16.6M
L'ORÉAL	+0.10%	+0.20%	+4.86%	-7.78%	233B
GALDERMA GROUP AG	+1.53%	-0.20%	+39.45%	-	50.18B
APR CO., LTD.	+1.95%	+4.80%	+121.03%	-	9.89B
SHISEIDO COMPANY, LIMITED	+1.19%	+11.07%	+27.77%	-51.60%	7.53B
AMOREPACIFIC CORPORATION	+2.98%	+1.06%	-9.66%	+16.15%	5.17B
ELF BEAUTY	-1.07%	-3.99%	-33.55%	-37.90%	4.34B
INTERPARFUMS, INC.	+0.42%	+3.31%	-5.55%	-8.43%	3.95B
PROYA COSMETICS CO.,LTD.	-5.80%	-1.72%	-30.33%	-49.64%	3.28B
INTERPARFUMS	-1.28%	+1.87%	-19.39%	-47.78%	2.63B
Average	+0.13%	+1.05%	+8.66%	-29.76%	32.02B
Weighted average by Cap.	+0.37%	+0.55%	+12.97%	-10.02%

	2024	2025
Net sales	9.51M 10.88M 8.78M 8.09M 15.25M 1.05B 15.59M 105M 41.26M 513M 40.88M 39.98M 1.77B	10.5M 12.01M 9.69M 8.93M 16.83M 1.16B 17.2M 116M 45.54M 567M 45.12M 44.13M 1.95B
Net income	-2.92M -3.34M -2.69M -2.48M -4.68M -322M -4.78M -32.19M -12.66M -158M -12.54M -12.27M -542M	-4.86M -5.56M -4.48M -4.13M -7.79M -535M -7.96M -53.59M -21.08M -262M -20.88M -20.42M -903M
Net Debt	6.68M 7.65M 6.17M 5.68M 10.71M 736M 10.95M 73.71M 28.99M 361M 28.72M 28.09M 1.24B	4.19M 4.8M 3.87M 3.56M 6.72M 462M 6.87M 46.22M 18.18M 226M 18.01M 17.62M 779M